| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study
|
Jones, Stephen E
|
|
2013
|
14 |
11 |
p. 1121-1128
|
artikel
|
| 2 |
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis
|
Liao, Wei-Chih
|
|
2013
|
14 |
11 |
p. 1095-1103
|
artikel
|
| 3 |
Air pollution and lung cancer in Europe
|
Sax, Sonja N
|
|
2013
|
14 |
11 |
p. e439-e440
|
artikel
|
| 4 |
Air pollution and lung cancer in Europe – Authors' reply
|
Raaschou-Nielsen, Ole
|
|
2013
|
14 |
11 |
p. e440
|
artikel
|
| 5 |
Anthracycline-free therapy for HER2-amplified breast cancer
|
Gennari, Alessandra
|
|
2013
|
14 |
11 |
p. 1037-1038
|
artikel
|
| 6 |
Anti-EGFR treatment and RAS-family mutations
|
Bennet, Neil
|
|
2013
|
14 |
11 |
p. e445
|
artikel
|
| 7 |
Bayesian analysis unravels pancreas-cancer adjuvant therapy
|
Neoptolemos, John P
|
|
2013
|
14 |
11 |
p. 1034-1035
|
artikel
|
| 8 |
Benjamin Scheuer: The Bridge
|
Ranscombe, Peter
|
|
2013
|
14 |
11 |
p. 1054
|
artikel
|
| 9 |
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
|
Cunningham, David
|
|
2013
|
14 |
11 |
p. 1077-1085
|
artikel
|
| 10 |
Cabozantinib for patients with medullary thyroid cancer
|
Yaqub, Farhat
|
|
2013
|
14 |
11 |
p. e444
|
artikel
|
| 11 |
Cancer care in northern England rated best in England
|
Burki, Talha Khan
|
|
2013
|
14 |
11 |
p. e445
|
artikel
|
| 12 |
Challenges of accessing cancer medicines in Australia
|
Olver, Ian
|
|
2013
|
14 |
11 |
p. 1040-1042
|
artikel
|
| 13 |
Drinking alcohol before first pregnancy ups breast cancer risk
|
Tanday, Sanjay
|
|
2013
|
14 |
11 |
p. e442
|
artikel
|
| 14 |
Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study
|
Ornish, Dean
|
|
2013
|
14 |
11 |
p. 1112-1120
|
artikel
|
| 15 |
Engaging NGOs in national cancer-control efforts
|
Dunn, Jeff
|
|
2013
|
14 |
11 |
p. 1044-1046
|
artikel
|
| 16 |
Failure of anti-EGFR therapy in p16-positive head and neck cancer
|
Roesler, Rafael
|
|
2013
|
14 |
11 |
p. e436-e437
|
artikel
|
| 17 |
Failure of anti-EGFR therapy in p16-positive head and neck cancer – Authors' reply
|
Vermorken, Jan B
|
|
2013
|
14 |
11 |
p. e437-e438
|
artikel
|
| 18 |
Genetic cause of common childhood leukaemia revealed
|
Tanday, Sanjay
|
|
2013
|
14 |
11 |
p. e444
|
artikel
|
| 19 |
Good Clean Food
|
Hill, Emma
|
|
2013
|
14 |
11 |
p. 1053
|
artikel
|
| 20 |
Histone deacetylase inhibitors in multiple myeloma
|
Pratt, Guy
|
|
2013
|
14 |
11 |
p. 1038-1039
|
artikel
|
| 21 |
HSIL linked to anal cancer in MSM with HIV
|
Bagcchi, Sanjeet
|
|
2013
|
14 |
11 |
p. e446
|
artikel
|
| 22 |
Hypofractionated breast radiation: preferred standard of care?
|
Haffty, Bruce G
|
|
2013
|
14 |
11 |
p. 1032-1034
|
artikel
|
| 23 |
Immunological checkpoint inhibitors enter adolescence
|
Nowak, Anna K
|
|
2013
|
14 |
11 |
p. 1035-1037
|
artikel
|
| 24 |
Improvement of surgical results for pancreatic cancer
|
Hartwig, Werner
|
|
2013
|
14 |
11 |
p. e476-e485
|
artikel
|
| 25 |
Intercalated chemotherapy and erlotinib: a viable first-line option for patients with advanced NSCLC?
|
Zheng, Yulong
|
|
2013
|
14 |
11 |
p. e438
|
artikel
|
| 26 |
Intercalated chemotherapy and erlotinib: a viable first-line option for patients with advanced NSCLC? – Authors' reply
|
Mok, Tony S K
|
|
2013
|
14 |
11 |
p. e438-e439
|
artikel
|
| 27 |
Is cancer gene therapy an empty suit?
|
Brenner, Malcolm K
|
|
2013
|
14 |
11 |
p. e447-e456
|
artikel
|
| 28 |
Low-toxicity treatment for colorectal cancer in elderly people
|
Kubicka, Stefan
|
|
2013
|
14 |
11 |
p. 1031-1032
|
artikel
|
| 29 |
Multigene assays for late recurrence of breast cancer
|
Ignatiadis, Michail
|
|
2013
|
14 |
11 |
p. 1029-1030
|
artikel
|
| 30 |
New gene biomarker identified for indolent prostate cancer
|
Siva, Nayanah
|
|
2013
|
14 |
11 |
p. e446
|
artikel
|
| 31 |
New hope for relapsed and refractory multiple myeloma
|
Leleu, Xavier
|
|
2013
|
14 |
11 |
p. 1028-1029
|
artikel
|
| 32 |
NICE guidance on everolimus in combination with exemestane for treatment of advanced HER2-negative, hormone-receptor-positive breast cancer after endocrine therapy
|
Burke, Martyn J
|
|
2013
|
14 |
11 |
p. 1049-1050
|
artikel
|
| 33 |
Patent rulings raise hope for cheap cancer drugs in India
|
Sharma, Dinesh C
|
|
2013
|
14 |
11 |
p. e441
|
artikel
|
| 34 |
Pazopanib or sunitinib for metastatic renal-cell carcinoma?
|
Bennet, Neil
|
|
2013
|
14 |
11 |
p. e442
|
artikel
|
| 35 |
PET imaging of oestrogen receptors in patients with breast cancer
|
van Kruchten, Michel
|
|
2013
|
14 |
11 |
p. e465-e475
|
artikel
|
| 36 |
Pixantrone or doxorubicin for diffuse large B-cell lymphoma?
|
Sharma, Sharan Prakash
|
|
2013
|
14 |
11 |
p. e441
|
artikel
|
| 37 |
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
|
Miguel, Jesus San
|
|
2013
|
14 |
11 |
p. 1055-1066
|
artikel
|
| 38 |
p16 post-hoc analyses and Simpson's paradox
|
Kyrgidis, Athanassios
|
|
2013
|
14 |
11 |
p. e436
|
artikel
|
| 39 |
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
|
Sgroi, Dennis C
|
|
2013
|
14 |
11 |
p. 1067-1076
|
artikel
|
| 40 |
Present status and future directions of intraoperative radiotherapy
|
Debenham, Brock J
|
|
2013
|
14 |
11 |
p. e457-e464
|
artikel
|
| 41 |
Radiation disasters: an international biobank plan is vital
|
Shaw, David
|
|
2013
|
14 |
11 |
p. 1042-1043
|
artikel
|
| 42 |
Rights violation found in HPV vaccine studies in India
|
Sharma, Dinesh C
|
|
2013
|
14 |
11 |
p. e443
|
artikel
|
| 43 |
Stop smoking services in England help break the habit
|
Burki, Talha Khan
|
|
2013
|
14 |
11 |
p. e443
|
artikel
|
| 44 |
Stories We Tell
|
Hill, Emma
|
|
2013
|
14 |
11 |
p. 1053
|
artikel
|
| 45 |
The proton problem
|
Halperin, Edward C
|
|
2013
|
14 |
11 |
p. 1046-1048
|
artikel
|
| 46 |
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
|
Haviland, Joanne S
|
|
2013
|
14 |
11 |
p. 1086-1094
|
artikel
|
| 47 |
Time for e-cigarette regulation
|
The Lancet Oncology,
|
|
2013
|
14 |
11 |
p. 1027
|
artikel
|
| 48 |
Transparency in reporting clinical trials
|
Yaqub, Farhat
|
|
2013
|
14 |
11 |
p. 1051-1053
|
artikel
|
| 49 |
Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
|
Calabrò, Luana
|
|
2013
|
14 |
11 |
p. 1104-1111
|
artikel
|
| 50 |
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
|
Dimopoulos, Meletios
|
|
2013
|
14 |
11 |
p. 1129-1140
|
artikel
|
Tijdschrift beschrijving